Fuery, Michael A.
Kadhim, Bashar
Samsky, Marc D.
Freeman, James V.
Clark, Katherine
Desai, Nihar R.
Wilson, Francis P.
Ahmed, Treeny
Ahmad, Tariq
Article History
Accepted: 15 June 2023
First Online: 8 August 2023
Declarations
:
: Michael Fuery, Marc Samsky, Katherine Clark, Treeny Ahmed, Bashar Kadhim declare that they have no conflict of interest.F. Perry Wilson is supported by R01DK113191 and R01HS027626 and has received research support from Whoop, Inc., AstraZenca, Amgen, Boeringher-Ingelheim, and Vifor Pharma.Dr. Freeman reports salary support from the American College of Cardiology (ACC) National Cardiovascular Data Registry and the NHLBI and consulting/advisory board fees from Boston Scientific, Medtronic, PaceMate, and Biosense Webster. He has equity in PaceMate.Nihar Desai works under contract with the Centers for Medicare and Medicaid Services to develop and maintain performance measures used for public reporting and pay for performance programs. He reports research grants and consulting for Amarin, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Novartis, SCPharmaceuticals, and Vifor.Tariq Ahmad has received consulting fees from Sanofi, Amgen, and Cytokinetics, and has received research funding from Boehringer Ingelheim, AstraZeneca, Cytokinetics, and Relypsa.All authors report that no relationships are relevant to the contents of this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.